Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib

Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib

Background The remarkable efficacy of osimertinib in non‒small cell lung cancer (NSCLC) with acquired T790M mutation has been widely documented in clinical trials and real-world practice. However, some patients show primary resistance to this drug. Even patients who initially show a favorable respon...

Full description

Bibliographic Details
Main Authors: Ji Young Park, Seung Hun Jang, Chang Youl Lee, Taehee Kim, Soo Jie Chung, Ye Jin Lee, Hwan Il Kim, Joo-Hee Kim, Sunghoon Park, Yong Il Hwang, Ki-Suck Jung
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2022-04-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
non‒small cell lung carcinoma
osimertinib
receptor, epidermal growth factor
Online Access:http://www.e-trd.org/upload/pdf/trd-2021-0139.pdf

Internet

http://www.e-trd.org/upload/pdf/trd-2021-0139.pdf

Similar Items